Acadia Healthcare Company, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.80 | $0.80 | $0.80 |
Q2 2024 | 4 | $0.87 | $0.88 | $0.88 |
Q3 2024 | 3 | $0.90 | $0.90 | $0.90 |
Q4 2024 | 9 | $0.67 | $0.83 | $0.72 |
Q1 2025 | 8 | $0.76 | $0.89 | $0.81 |
Q2 2025 | 5 | $0.93 | $0.97 | $0.95 |
Q3 2025 | 4 | $0.98 | $1.02 | $1.00 |
Q4 2025 | 5 | $0.83 | $0.87 | $0.85 |
Q1 2026 | 3 | $0.91 | $0.95 | $0.92 |
Q2 2026 | 4 | $1.07 | $1.11 | $1.09 |
Q3 2026 | 3 | $1.10 | $1.14 | $1.12 |
Q4 2026 | 4 | $0.99 | $1.03 | $1.01 |
Acadia Healthcare Company, Inc. Earnings Date And Information
Acadia Healthcare Company, Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.9 by $0.01. The company had revenue of 815.63 M for the quarter and had revenue of 2.93 B for the year. Acadia Healthcare Company, Inc. has generated $0 earnings per share over the last year ($-0.24 diluted earnings per share) and currently has a price-to-earnings ratio of 12.53. Acadia Healthcare Company, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Acadia Healthcare Company, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/30/2024 | Q3 2024 | $0.90 | $0.74 | -0.16 | $819.42 M | $815.63 M |
08/01/2024 | Q2 2024 | $0.86 | $785.73 M | $796.04 M | ||
05/02/2024 | Q1 2024 | $0.84 | $768.05 M | |||
02/28/2024 | Q4 2023 | $0.63 | $742.80 M | |||
11/03/2023 | Q3 2023 | -$2.39 | $726.23 M | $750.33 M | ||
07/28/2023 | Q2 2023 | $0.79 | $711.92 M | $731.34 M | ||
04/27/2023 | Q1 2023 | $0.73 | $704.27 M | |||
02/28/2023 | Q4 2022 | $0.68 | $675.30 M | |||
11/02/2022 | Q3 2022 | $0.79 | $657.50 M | $666.73 M | ||
07/28/2022 | Q2 2022 | $0.89 | $650.82 M | $651.72 M | ||
05/04/2022 | Q1 2022 | $0.68 | $616.65 M | |||
03/01/2022 | Q4 2021 | $0.79 | $593.48 M | |||
10/29/2021 | Q3 2021 | $0.74 | $591.41 M | $587.56 M | ||
08/03/2021 | Q2 2021 | $0.50 | $560.76 M | $582.16 M | ||
04/30/2021 | Q1 2021 | $0.11 | $551.20 M | |||
02/26/2021 | Q4 2020 | -$8.91 | $541.28 M | |||
10/30/2020 | Q3 2020 | $0.42 | $800.25 M | $833.30 M | ||
08/05/2020 | Q2 2020 | $0.47 | $763.07 M | $750.31 M | ||
05/05/2020 | Q1 2020 | $0.38 | $782.81 M | |||
02/28/2020 | Q4 2019 | -$0.13 | $780.23 M |
Acadia Healthcare Company, Inc. Earnings: Frequently Asked Questions
-
When is Acadia Healthcare Company, Inc.'s earnings date?
Acadia Healthcare Company, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
Did Acadia Healthcare Company, Inc. beat their earnings estimates last quarter?
In the previous quarter, Acadia Healthcare Company, Inc. (:ACHC) reported $0.91 earnings per share (EPS) to beat the analysts' consensus estimate of $0.9 by $0.01.
-
How can I listen to Acadia Healthcare Company, Inc.'s earnings conference call?
The conference call for Acadia Healthcare Company, Inc.'s latest earnings report can be listened to online.
-
How can I read Acadia Healthcare Company, Inc.'s conference call transcript?
The conference call transcript for Acadia Healthcare Company, Inc.'s latest earnings report can be read online.
-
How much revenue does Acadia Healthcare Company, Inc. generate each year?
Acadia Healthcare Company, Inc. (:ACHC) has a recorded annual revenue of $2.93 B.
-
How much profit does Acadia Healthcare Company, Inc. generate each year?
Acadia Healthcare Company, Inc. (:ACHC) has a recorded net income of $2.93 B. Acadia Healthcare Company, Inc. has generated $-0.24 earnings per share over the last four quarters.
-
What is Acadia Healthcare Company, Inc.'s price-to-earnings ratio?
Acadia Healthcare Company, Inc. (:ACHC) has a price-to-earnings ratio of 12.53 and price/earnings-to-growth ratio is 0.